Several in vitro and in vivo non-ion channel studies have shown that diabetes-related hyperglycemia, insulin resistance, inflammatory cytokines, and oxidative stress can activate PKC and ERK [9, 10, 36–38]. The gene discussed is PRRT2; the disease is diabetes mellitus.